A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss

BACKGROUND: The delivery of treatment agents to inner ear with drug delivery system (DDS) has been under investigation to overcome the limitations of the conventional therapeutic agents in curing or alleviating the cisplatin ototoxicity. METHODS: In the present study, a novel targeted dexamethasone...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xueling, Chen, Yuming, Tao, Yong, Gao, Yunge, Yu, Dehong, Wu, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241721/
https://www.ncbi.nlm.nih.gov/pubmed/30532536
http://dx.doi.org/10.2147/IJN.S170130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6241721/
https://www.ncbi.nlm.nih.gov/pubmed/30532536
http://dx.doi.org/10.2147/IJN.S170130

Ejemplares similares